Loss of Salmeterol Bronchoprotection against Exercise in Relation to ADRB2 Arg16Gly Polymorphism and Exhaled Nitric Oxide

Rationale: β(2)-Agonists are the treatment of choice for exercise-induced bronchoconstriction (EIB) and act through specific receptors (ADRB2). Arg16Gly polymorphisms have been shown to affect responses to regular use of β(2)-agonists. Objectives: To evaluate the influence of the Arg16Gly receptor p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bonini, Matteo, Permaul, Perdita, Kulkarni, Tejaswini, Kazani, Shamsah, Segal, Alex, Sorkness, Christine A., Wechsler, Michael E., Israel, Elliot
Formato: Artigo
Idioma:Inglês
Publicado em: American Thoracic Society 2013
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3917379/
https://ncbi.nlm.nih.gov/pubmed/24228710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201307-1323OC
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados